Liquidia Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LT4.SG | TRVI | INVA | LNTH | INSM | LP6.F | |
|---|---|---|---|---|---|---|
| Market cap | 3.60B | 1.99B | 1.54B | 6.60B | 24.13B | 2.33B |
| P/E (TTM) | — | — | 5.0 | 24.5 | — | 11.9 |
| Forward P/E | — | -24.2 | 9.6 | 15.6 | 168.1 | — |
| Price/book | 21.6 | 6.2 | 1.4 | 5.0 | 33.2 | 1.3 |
| Dividend yield | — | — | — | — | — | 7.18% |
| 1-year change | +74.65% | +30.26% | +3.30% | +88.38% | −40.76% | −23.98% |
| Today | +0.60% | +0.90% | +1.58% | +0.34% | +5.32% | +0.77% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All LT4.SG news ›Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Eli Lilly & Co (LLY) and Liquidia Technologies (LQDA)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zoetis (ZTS), Eli Lilly & Co (LLY) and Liquidia Technologies (LQDA). Leerink Partners analyst Daniel Clark reiterated a Hold rating on Zoetis…
What Is Behind Liquidia’s Lead Over Its Industry?
Over the past five years, one drugmaker outperformed all 60 of its measurable pharmaceutical peers. That company is Liquidia Corporation (LQDA) (LQDA), the manufacturer of YUTREPIA, an inhalation powder form of the drug treprostinil.…
LQDA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Liquidia Corporation (LQDA)
The dollar exposure is specific. Liquidia reported $300.3 million in Yutrepia sales for the first six months of 2026, including approximately $129.9 million in the first quarter. Its Q2 2026 Form 10-Q listed approximately $69.1 million in…
Liquidia Is A Bargain Today
Arquitos Capital details Liquidia's legal settlement with United Therapeutics and its path forward. Read the full analysis for more details. - Liquidia will pay a net of $380.7 million in multiple installments in 2026 and 2027. - The…
Liquidia Stock Soars More Than 26% After $380.7 Million Settlement Ends Legal War With United Therapeutics
NEW YORK — Shares of Liquidia surged Wednesday after the drugmaker agreed to pay United Therapeutics $380.7 million to settle a yearslong legal fight over its inhaled lung disease treatment, removing a major threat that had wiped out more…
Head-To-Head Contrast: Liquidia (NASDAQ:LQDA) and SCYNEXIS (NASDAQ:SCYX)
Posted by Kim Johansen on Oct 19th, 2026 Liquidia (NASDAQ:LQDA – Get Free Report) and SCYNEXIS (NASDAQ:SCYX – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the…
StockWatch: Liquidia Rebounds After Settling Legal Wrangle with United Therapeutics
Two weeks after 57% plunge, shares surge 25% over three days after companies end six lawsuits that encompassed patent infringement, trade secret, and antitrust claims Two weeks after its stock lost more than half its value following a…
Liquidia Stock Gets Stronger EPS Estimate from HC Wainwright
Posted by Defense World Staff on Oct 19th, 2026 Here are the key news stories impacting Liquidia this week: Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with serious…
Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure
Wall Street analysts warmed to Crocs Inc. (CROX) and Liquidia Corp. (LQDA) on growth potential and easing legal risks, while Albertsons Companies (ACI) faced downgrades from three firms. Meanwhile, SpaceX’s growing ambitions rattled…
Morrisville’s Liquidia Settles All Litigation With United Therapeutics, Keeping YUTREPIA Available for PAH Patients
The settlement includes mutual releases and is not an admission of liability by either party. After Liquidia’s initial payment, the parties will dismiss with prejudice six matters spanning patent infringement, trade secret, breach of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com19
- stocktitan.net7
- tradingview.com6
- seekingalpha.com5
- marketbeat.com4
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 80 articles, not a forecast.